PIPERACILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Piperacillin patents expire, and what generic alternatives are available?
Piperacillin is a drug marketed by Istituto Bio Ita Spa, Astral, Eugia Pharma, Eugia Pharma Speclts, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Provepharm Sas, Sagent Pharms Inc, Sandoz, Shandong, Steriscience Speclts, and Wockhardt Bio Ag. and is included in twenty-four NDAs.
The generic ingredient in PIPERACILLIN is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIPERACILLIN?
- What are the global sales for PIPERACILLIN?
- What is Average Wholesale Price for PIPERACILLIN?
Summary for PIPERACILLIN
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 24 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 101 |
| Patent Applications: | 4,647 |
| Drug Prices: | Drug price information for PIPERACILLIN |
| DailyMed Link: | PIPERACILLIN at DailyMed |
Recent Clinical Trials for PIPERACILLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scandinavian Critical Care Trials Group | Phase 4 |
| University Hospital, Rouen | Phase 3 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 |
US Patents and Regulatory Information for PIPERACILLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 203557-001 | Oct 29, 2014 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sagent Pharms Inc | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 208674-002 | Feb 16, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Steriscience Speclts | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 065458-003 | Aug 15, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Shandong | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 204959-003 | Aug 10, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Wockhardt Bio Ag | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 206996-001 | Mar 22, 2017 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
